362 related articles for article (PubMed ID: 29740351)
1. Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.
Severino AL; Shadfar A; Hakimian JK; Crane O; Singh G; Heinzerling K; Walwyn WM
Front Psychiatry; 2018; 9():119. PubMed ID: 29740351
[TBL] [Abstract][Full Text] [Related]
2. Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.
Kibaly C; Alderete JA; Liu SH; Nasef HS; Law PY; Evans CJ; Cahill CM
Cell Mol Neurobiol; 2021 Jul; 41(5):899-926. PubMed ID: 33245509
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
[TBL] [Abstract][Full Text] [Related]
4. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
Cicero TJ; Ellis MS
JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
[TBL] [Abstract][Full Text] [Related]
5. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
6. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
[TBL] [Abstract][Full Text] [Related]
7. Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER.
Geoffrey Severtson S; Kreider SED; Amioka EC; Margolin ZR; Iwanicki JL; Dart RC
Pain Med; 2020 Dec; 21(12):3660-3668. PubMed ID: 33094329
[TBL] [Abstract][Full Text] [Related]
8. Prescription opioid abuse, pain and addiction: clinical issues and implications.
Ling W; Mooney L; Hillhouse M
Drug Alcohol Rev; 2011 May; 30(3):300-5. PubMed ID: 21545561
[TBL] [Abstract][Full Text] [Related]
9. Opioids with abuse-deterrent properties: A regulatory and technological overview.
Haddox JD
J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
[TBL] [Abstract][Full Text] [Related]
10. Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties.
Cheng HG; Coplan PM
Postgrad Med; 2018 Aug; 130(6):568-574. PubMed ID: 29978755
[TBL] [Abstract][Full Text] [Related]
11. Tamper-resistant opioid formulations in the treatment of acute pain.
Passik SD
Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323
[TBL] [Abstract][Full Text] [Related]
12. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
13. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
14. Opioid epidemic in the United States.
Manchikanti L; Helm S; Fellows B; Janata JW; Pampati V; Grider JS; Boswell MV
Pain Physician; 2012 Jul; 15(3 Suppl):ES9-38. PubMed ID: 22786464
[TBL] [Abstract][Full Text] [Related]
15. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
16. Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations.
Anne S; Mims JW; Tunkel DE; Rosenfeld RM; Boisoneau DS; Brenner MJ; Cramer JD; Dickerson D; Finestone SA; Folbe AJ; Galaiya DJ; Messner AH; Paisley A; Sedaghat AR; Stenson KM; Sturm AK; Lambie EM; Dhepyasuwan N; Monjur TM
Otolaryngol Head Neck Surg; 2021 Apr; 164(2_suppl):S1-S42. PubMed ID: 33822668
[TBL] [Abstract][Full Text] [Related]
17. Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.
Kumar VM; Agboola F; Synnott PG; Segel C; Webb M; Ollendorf DA; Banken R; Chapman RH
Value Health; 2019 Apr; 22(4):416-422. PubMed ID: 30975392
[TBL] [Abstract][Full Text] [Related]
18. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334
[TBL] [Abstract][Full Text] [Related]
19. Use of risk mitigation practices by family nurse practitioners prescribing opioids for the management of chronic nonmalignant pain.
Chaudhary S; Compton P
Subst Abus; 2017; 38(1):95-104. PubMed ID: 27897471
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
